Anika Therapeutics Profit Margin 2006-2021 | ANIK
Current and historical gross margin, operating margin and net profit margin for Anika Therapeutics (ANIK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Anika Therapeutics net profit margin as of June 30, 2021 is -9.28%.
|Anika Therapeutics Annual Profit Margins
|Anika Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.